A special discussion was conducted between Outside Director Yoshihisa Suzuki and Chief Strategy Officer (CSO) Yasuo Fujii. Here, they exchange opinions from their respective standpoints on supervision and execution regarding the leadup to formulating the background of the Story for Vision 2030 announced in 2024 and subsequent progress.
*Investors only. Please refer to page 24 of Integrated Report 2024.
Story for Vision 2030
More Kyowa Kirin "Growth" Stories
Rare Disease Day 2025: Spreading Awareness and Support Holding Events Worldwide
Patients | August 29, 2025
Enhancing Patient-Centric Activities in Japan region’s Medical Affairs Department (MA Department): A Seminar with Guest Speakers, Including a Patient
Patients | August 19, 2025
Special Dialogue between the CEO & COO: Together, Pioneering New Horizons
Growth | July 24, 2025
“Healthcare Café” Report ─ A Platform for Patient Dialogue: Thinking About Hematopoietic Stem Cell Transplantation (Part One)
Patients | July 23, 2025
“Healthcare Café” Report ─ A Platform for Patient Dialogue: Thinking About Hematopoietic Stem Cell Transplantation (Part Two)
Patients | July 23, 2025
Special Discussion: Story for Vision 2030
Growth | June 23, 2025
PRIDE MONTH Message from Abdul Mullick, President and COO
People & Culture | June 2, 2025
Listening to Patients’ Voice and Responding to Their Needs: Kyowa Kirin's Patient Engagement Activities
Patients | March,18, 2025
Kyowa Kirin CPO Itagaki’s message for International Women’s Day
People & Culture | March 7, 2025
What is the Kyowa Kirin Group’s health and productivity management initiative, Wellness Action 2025?
People & Culture | February 10, 2025
Rare Disease Day 2025 - More Than You Can Imagine
Patients | February,7, 2025
Kyowa Kirin CEO Miyamoto’s New Year Message: Accelerate Our Reforms with Determination for Delivering Life-changing Value to Patients
Growth | January 14, 2025
Kyowa Kirin Hosted Booth at Tokyo Rainbow Pride 2024 for a Second Year in a Row: Initiatives for Accelerating DE&I and the Ideal State a Company Should Strive to Be (Part One)
People & Culture | October 15, 2024
Kyowa Kirin Hosted Booth at Tokyo Rainbow Pride 2024 for a Second Year in a Row: Initiatives for Accelerating DE&I and the Ideal State a Company Should Strive to Be (Part Two)
People & Culture | October 15, 2024
Strengthening our training framework to tackle the biopharmaceutical engineer shortage
People & Culture | September 20, 2024
Highlighting Kyowa Kirin's initiatives across regions for PRIDE MONTH 2024
People & Culture | September 13, 2024
Bio Adventure: Kyowa Kirin’s works with local communities on project to foster future scientists
People & Culture | August 9, 2024
PRIDE MONTH Message from Jeremy Morgan, President, Kyowa Kirin International plc (EMEA region)
People & Culture | July 5, 2024
Kyowa Kirin launches the CTCL Global Care Collaborative’s Time to Act global consensus statement
Patients | May 13, 2024
Kyowa Kirin Global Corporate Planning Head Shoko Itagaki’s Message for International Women's Day
People & Culture | March 8, 2024
Kyowa Kirin CEO Miyamoto’s New Year Message
Growth | January 9, 2024
Kyowa Kirin Chief International Business Officer Abdul Mullick’s Message on UN’s International Day of Persons with Disabilities
Sustainability | December 1, 2023
Kyowa Kirin hosted a booth for the first time at the Tokyo Rainbow Pride 2023 [Our Diversity, Equity & Inclusion]
People & Culture | November 9, 2023
Our Stable Supply of High-quality Pharmaceuticals
Sustainability | September 20, 2023
Provide pharmaceuticals for unmet medical needs - A Conversation with Kyowa Kirin’s R&D Executives
Innovation | August 22, 2023
Ensure a Thriving Global Environment for Future Generations
Sustainability | July 28, 2023
“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅡ
People & Culture | June 9, 2023
“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅠ
People & Culture | April 25, 2023
Kyowa Kirin CEO Miyamoto’s Message on Rare Disease Day
Patients | February 28, 2023
Promoting patient advocacy and nurturing patient-centric care: Interview with Kyowa Kirin North America
Patients | February 14, 2023
Celebrating another year of diverse initiatives around the world: RDD 2022 in EMEA
Patients | January 24, 2023
Celebrating another year of diverse initiatives around the world: RDD 2022 in North America
Patients | December 15, 2022
Celebrating another year of diverse initiatives around the world: RDD 2022 in Asia Pacific
Patients | November 21, 2022
Celebrating another year of diverse initiatives around the world: RDD 2022 in Japan
Patients | October 20, 2022
Providing high-quality pharmaceuticals to patients around the world
Sustainability | September 22, 2022
Striving to create life-changing “Only-one value” that brings smiles to patients
Innovation | July 25, 2022
Kyowa Kirin International: It's Time to Shine A Light on XLH
Patients | June 27, 2022
Kyowa Kirin CEO Miyamoto’s Message on Pride Month
People & Culture | June 9, 2022
Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA
People & Culture | January 20, 2022
Kyowa Kirin International: Around the world challenge
People & Culture | December 17, 2021
Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month
Patients | November 19, 2021
Kyowa Kirin's Effort to Realize a Sustainable Society
Sustainability | October 11, 2021
Our Financial Strategy for Creating Life-changing Value
Growth | September 9, 2021
Changes in society caused by COVID-19 and the impact on Kyowa Kirin
Growth | August 19, 2021
Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break
Sustainability | July 27, 2021
AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS
News Release | June 1, 2021
MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting
News Release | May 20, 2021
White Paper on the unrecognized burden of XLH in adults in Europe
Patients | July 13, 2020
Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (First Half)
People & Culture | March 5, 2020
Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (Second Half)
People & Culture | March 5, 2020
“Delivering smiles with sports” Creating an inclusive society through table tennis
Sustainability | January 14, 2020
Bio Adventure*: Kyowa Kirin Invites Children to a Science Adventure
People & Culture | July 3, 2019
